Windows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallCrashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minuteiTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
If you develop a fever or another new symptom after CAR-T therapy, contact your CAR-T care team promptly and follow the instructions they gave you. Cytokine release syndrome (CRS) can be mild or life-threatening, and symptoms such as breathing trouble, confusion, seizures, or signs of low blood pressure need urgent medical assessment. This guide can help you recognize warning signs, but it cannot diagnose CRS or replace your treatment team’s directions.
What are the signs of cytokine release syndrome after CAR-T therapy?
CRS is an inflammatory reaction that can happen when CAR T cells activate and release cytokines. It may cause symptoms ranging from fever and flu-like feelings to serious breathing or circulation problems. The National Cancer Institute (NCI) lists fever, nausea, headache, rash, a rapid heartbeat, low blood pressure, and trouble breathing as possible symptoms (NCI overview of T-cell transfer therapy; NCI definition of cytokine release syndrome).
The NIH Clinical Center’s patient education sheet also lists chills, flu-like symptoms, muscle aches, and changes in thinking or behavior, including confusion or memory loss. Seizures are another listed warning sign (NIH Clinical Center CAR T-cell patient education).
- Fever or flu-like symptoms: fever, chills, muscle aches, or feeling generally unwell.
- Other possible symptoms: headache, nausea, or rash.
- Heart and circulation symptoms: a fast heartbeat or low blood pressure.
- Breathing symptoms: shortness of breath or other trouble breathing.
- Neurologic or behavior changes: confusion, memory changes, difficulty finding words, unusual sleepiness, or seizures.
These symptoms do not confirm CRS. They can have other causes, and some neurologic changes may indicate immune effector cell-associated neurotoxicity syndrome (ICANS), a distinct CAR-T complication. Your care team must assess the cause and severity.
#1 Best Overall
When should I call my CAR-T care team?
Tell your CAR-T team promptly about symptoms they have told you to report, including fever or new flu-like symptoms. Ask the team which symptoms require a call, what number to use, and whether any symptom can be managed at home; NCI specifically advises patients to get these instructions from their care team (NCI: Flu Symptoms and Cancer Treatment). Follow your program’s temperature threshold and contact plan rather than applying a general fever cutoff to every CAR-T patient.
Seek urgent medical assessment for severe or rapidly worsening symptoms—especially trouble breathing, confusion or other major neurologic changes, a seizure, or signs of circulatory problems such as low blood pressure or a very fast heartbeat. If symptoms are severe, use the emergency instructions provided by your treatment team or local emergency services; do not wait for a routine callback.
Make the call easier
- Keep your CAR-T team’s daytime and after-hours contact details readily available.
- When reporting symptoms, describe what changed, when it began, and whether it is getting worse. If you checked your temperature, give the reading and time.
- Use only the fever thresholds and home-care steps your treatment team gave you. A thermometer can help measure temperature, but it cannot diagnose CRS or replace contacting the team.
When can CRS symptoms begin?
The NIH Clinical Center says CRS signs generally occur within one to two weeks after infusion, but they can arise at any time, including several weeks later. That is general patient-education guidance, not a prediction of an individual patient’s risk window. Do not assume that being beyond the usual period rules out a concern; report symptoms according to your team’s instructions.
For covered autologous BCMA- and CD19-directed CAR-T products in the United States, the FDA’s June 26, 2025 safety communication describes updated labeling that advises monitoring for at least two weeks, including daily monitoring for at least one week, staying near a healthcare facility for at least two weeks, and avoiding driving for two weeks after administration. These are FDA labeling recommendations for the covered products; your treatment team will give you the plan that applies to your therapy. The FDA also reported that these products retain boxed warnings and Medication Guides addressing CRS and neurologic toxicity (FDA safety communication, June 26, 2025).
How is CRS treated?
CRS is assessed and treated by clinicians, who determine its severity and the appropriate response. NCI notes that tocilizumab and, when needed, steroids are used for many patients (NCI: CAR T Cells—Engineering Immune Cells to Treat Cancer). Do not try to treat suspected CRS yourself or use a symptom list to decide that it is safe to delay contacting your team.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Why symptoms cannot predict what will happen next
CRS can vary in timing and severity, and symptoms may also point to other urgent problems. As the NCI explains in its patient guidance, “Doctors and nurses cannot know for sure when or if side effects will occur or how they will affect you.” That uncertainty is why the treatment team’s reporting and emergency instructions matter even when a symptom seems familiar or mild.
Quick Recap
Best Value
- CAR T Man Unleashing the Genetic Marvel of CAR-T-Cell Therapy! Coloring Book is a captivating and heartwarming story that follows the journey of a hero dad, his family, and their beloved dog Blaze as they navigate through multiple levels of cancer treatments.
- The story is designed to inspire and uplift families who are facing similar challenges, providing them with hope and encouragement during their journey.
- The story is filled with real life illustrations that bring the characters to life and convey the emotional journey of the family as they face down the relentless cancer villain.
- This coloring book is not only a fun and engaging activity for kids, but also a powerful tool for educating them about the importance of cancer research, the benefits of CAR T Cell Therapy, and the resilience of the human spirit.
- A true story of a family and the ups and downs victories and defeats in the battle against cancer that will inspire hope, and positivity for the whole family.
Rank #4
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →
